Completion of Acclaim-1 dose escalation: Recommended Phase 2 dose of quaratusugene ozeplasmid gene therapy and Osimertinib

被引：0
|
作者：
Spira, Alexander I.
Berz, David
Jotte, Robert M.
Pachipala, Krishna K.
Berger, Mark S.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-A065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A065
引用
收藏
页数：2
相关论文
共 50 条
  • [41] STAAR, a phase I/II study of isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Dose escalation phase results
    Hopkin, Robert J.
    Ganesh, Jaya
    Deegan, Patrick
    Goker-Alpan, Ozlem
    Bernat, John
    Wilcox, William R.
    Pahl, Madeleine V.
    Whitley, Chester B.
    Hughes, Derralynn
    Nicholls, Kathleen
    Cao, Liching
    Chen, Michael
    Shiue, Lisa H.
    Bowden, Emma
    Jaggumantri, Sravan
    Passalacqua, Cristobal
    Souberbielle, Bernard
    Cockroft, Bettina M.
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 61 - 62
  • [42] Dose Escalation to Target Volumes of Helical Tomotherapy for Pancreatic Cancer in the Phase 1-2 Clinical Trial
    Xia, T.
    Chang, D.
    Wang, Y.
    Li, J.
    Wu, W.
    Zhu, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S303 - S303
  • [43] A Phase 1 Dose-Escalation Study of Gemcitabine Plus Standard Radiation Therapy for Malignant High-Grade Gliomas
    Kim, M. M.
    Schipper, M.
    Cao, Y.
    Junck, L.
    Marnmoser, A.
    Heth, J.
    Sagher, O.
    Lawrence, T. S.
    Tsien, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S282 - S282
  • [44] A PHASE 1 DOSE ESCALATION STUDY OF GCC19CART A NOVEL COUPLEDCAR® THERAPY FOR SUBJECTS WITH METASTATIC COLORECTAL CANCER
    Chen, Naifei
    Pu, Chengfei
    Zhao, Lingling
    Li, Ning
    Wang, Chang
    Huang, Yusheng
    Luo, Suxia
    Li, Xun
    Yang, Zhenzhou
    Bie, Jun
    Zhu, Ruihong
    Huang, Xi
    Tang, Haiyang
    Liang, Tingting
    Wang, Yizhuo
    Jia, Beibei
    Chen, Dongqi
    Kennedy, Eugene
    Wu, Zhao
    Song, Yongping
    Xiao, Lei
    Cui, Jiuwei
    Xiao, Lei
    Lu, Victor
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A683 - A683
  • [45] A phase 1 dose escalation study of GCC19CART-a novel CoupledCAR therapy for subjects with metastatic colorectal cancer
    Chen, Naifei
    Pu, Chengfei
    Zhao, Lingling
    Li, Ning
    Wang, Chang
    Huang, Yusheng
    Luo, Suxia
    Li, Xun
    Yang, Zhenzhou
    Bie, Jun
    Zhu, Ruihong
    Huang, Xi
    Tang, Haiyang
    Liang, Tingting
    Wang, Yizhuo
    Jia, Beibei
    Chen, Dongqi
    Wu, Zhao
    Song, Yongping
    Lu, Victor
    Xiao, Lei
    Cui, Jiuwei
    CANCER RESEARCH, 2023, 83 (07)
  • [46] Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study
    Alayed, Yasir
    Loblaw, Andrew
    Chu, William
    Al-Hanaqta, Motasem
    Chiang, Andrew
    Jain, Suneil
    Chung, Hans
    Vesprini, Danny
    Morton, Gerard
    Ravi, Ananth
    Davidson, Melanie
    Deabreu, Andrea
    Mamedov, Alexandre
    Zhang, Liying
    Erler, Darby
    Cheung, Patrick
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1066 - 1073
  • [47] A Phase 1 Dose Escalation Study of GCC19CART a Novel CoupledCAR® Therapy for Subjects with Metastatic Colorectal Cancer
    Chen, Naifei
    Pu, Chengfei
    Zhao, Lingling
    Li, Ning
    Wang, Chang
    Huang, Yusheng
    Luo, Suxia
    Li, Xun
    Yang, Zhenzhou
    Bie, Jun
    Zhu, Ruihong
    Huang, Xi
    Tang, Haiyang
    Liang, Tingting
    Wang, Yizhuo
    Jia, Beibei
    Chen, Dongqi
    Kennedy, Eugene
    Wu, Zhao
    Song, Yongping
    Xiao, Lei
    Cui, Jiuwei
    MOLECULAR THERAPY, 2022, 30 (04) : 402 - 403
  • [48] Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial
    Derby, Sarah
    Jackson, Mark R.
    Williams, Karin
    Stobo, Jamie
    Kelly, Caroline
    Sweeting, Lorna
    Shad, Shumaila
    Herbert, Christopher
    Short, Susan C.
    Williamson, Aoife
    James, Allan
    Nowicki, Stefan
    Bulbeck, Helen
    Chalmers, Anthony J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : 1371 - 1378
  • [49] Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer
    Ferreira, Miguel Reis
    Khan, Atia
    Thomas, Karen
    Truelove, Lesley
    McNair, Helen
    Gao, Annie
    Parker, Chris C.
    Huddart, Robert
    Bidmead, Margaret
    Eeles, Ros
    Khoo, Vincent
    van As, Nicholas J.
    Hansen, Vibeke N.
    Dearnaley, David P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (05): : 1234 - 1242
  • [50] Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
    Palfi, Stephane
    Gurruchaga, Jean Marc
    Ralph, G. Scott
    Lepetit, Helene
    Lavisse, Sonia
    Buttery, Philip C.
    Watts, Colin
    Miskin, James
    Kelleher, Michelle
    Deeley, Sarah
    Iwamuro, Hirokazu
    Lefaucheur, Jean Pascal
    Thiriez, Claire
    Fenelon, Gilles
    Lucas, Cherry
    Brugieres, Pierre
    Gabriel, Inanna
    Abhay, Kou
    Drouot, Xavier
    Tani, Naoki
    Kas, Aurelie
    Ghaleh, Bijan
    Le Corvoisier, Philippe
    Dolphin, Patrice
    Breen, David P.
    Mason, Sarah
    Guzman, Natalie Valle
    Mazarakis, Nicholas D.
    Radcliffe, Pippa A.
    Harrop, Richard
    Kingsman, Susan M.
    Rascol, Olivier
    Naylor, Stuart
    Barker, Roger A.
    Hantraye, Philippe
    Remy, Philippe
    Cesaro, Pierre
    Mitrophanous, Kyriacos A.
    LANCET, 2014, 383 (9923): : 1138 - 1146
12345